Martha E. Vincent
Chief Tech/Sci/R&D Officer at Agensys, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew Busch | M | 50 | 20 years | |
| Robert Eckert | M | 69 | 21 years | |
| Carl Gordon | M | 59 |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | - |
| Derek Miller | M | - | 21 years | |
| Teri Brunasso | F | - |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | - |
| Wolfgang Noe | M | - |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | 13 years |
| Claire Thomas | M | 68 |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | - |
| Koji Nagao | M | - |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | - |
| Mike Zahigian | M | - | 23 years | |
| Yoshitsuga Shitaka | M | - |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | - |
| Hideto Yamaguchi | M | - |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Donald B. Rice | M | 83 |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | 14 years |
| Madhavan Balachandran | M | 73 | 20 years | |
| Marc M. P. de Garidel | M | 66 | 15 years | |
| Kathryn Falberg | F | 63 | 6 years | |
| Michael Kelly | M | 67 | 14 years | |
| David W. Beier | M | 75 | 10 years | |
| Diana McKenzie | F | 59 | 12 years | |
| Anna Richo | F | 63 | 9 years | |
| Vasant Prakash Gandhi | M | - | 5 years | |
| Patricia Cary Sueltz | F | 71 | 2 years | |
| J. Reason | M | 83 | 12 years | |
| Sean E. Harper | M | 61 | 16 years | |
| Frank J. Biondi | M | 79 | 15 years | |
| Martin Simonetti | M | 66 | 7 years | |
| Craig Shepherd | M | - | 7 years | |
| Sef P. Kurstjens | M | 60 |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | 3 years |
| Preston Klassen | M | 55 | 7 years | |
| James Daly | M | 62 | 9 years | |
| John Smither | M | 71 | 6 years | |
| Jin Long Chen | M | 61 | 4 years | |
| Frans Gustaf Wuite | M | 64 | - | |
| Cynthia Flowers | F | 64 | 5 years | |
| John Moriarty | M | 56 | 6 years | |
| Alan C. Mendelson | M | 76 |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | - |
| Judith C. Pelham | F | 78 | 22 years | |
| Erin Lavelle | F | 46 | 15 years | |
| George Morrow | M | 72 | 10 years | |
| Jerry D. Choate | M | 86 | - | |
| Rachel Lenington | F | 51 | 10 years | |
| Patricia A. Turney | F | 57 | 23 years | |
| Brian M. McNamee | M | 67 | - | |
| David Baltimore | M | 86 | 21 years | |
| Timothy Martin | M | 55 | 3 years | |
| Arie Belldegrun | M | 74 |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | 11 years |
| William P. Sheridan | M | 69 | 5 years | |
| Frederick Gluck | M | 88 | 13 years | |
| Willard Dere | M | 70 | 11 years | |
| Thomas Zindrick | M | 65 | 8 years | |
| Dominique Monnet | M | 65 | 11 years | |
| Michael A. Grabow | M | - | 13 years | |
| Robert M. Brenner | M | 56 | 9 years | |
| H. Christian Fibiger | M | 80 | 4 years | |
| Andrew Gengos | M | 59 | 8 years | |
| Kent Stemper | M | - | 2 years | |
| Wen Chen | M | 56 | - | |
| Sesha Neervannan | M | 56 | 8 years | |
| Daniel Flynn | M | 70 | - | |
| Alex M. DePaoli | M | - | - | |
| Laura Hamill | F | 60 | 18 years | |
| Sandra Milligan | M | 60 | 10 years | |
| Brian Sweeney | M | 59 | 15 years | |
| Alan Barge | M | - | 8 years | |
| David Essayan | M | - | 4 years | |
| Xue Ming Qian | M | 57 | 13 years | |
| Catherine Stehman-Breen | M | 61 | 12 years | |
| David Hovland | M | - | 8 years | |
| Carl LeBel | M | 65 | 10 years | |
| Eric Grinstead | M | 66 | 7 years | |
| Ian McNiece | M | 70 | 1 years | |
| John G. Adair | M | - | 6 years | |
| Fabrizio Bonanni | M | 78 | 14 years | |
| Roger Perlmutter | M | 71 | 11 years | |
| Beth Seidenberg | M | 67 | 3 years | |
| Joseph P. Miletich | M | - | 12 years | |
| Robert S. Attiyeh | M | 90 | 4 years | |
| Carol Gallagher | M | 59 | 8 years | |
| John F. Weidenbruch | M | 63 | 10 years | |
| Larry Alan May | M | 74 | 15 years | |
| Doug Farrar | M | 59 | 7 years | |
| Timothy McNamara | M | 67 | 3 years | |
| Stephen Blackwood | M | 61 | 7 years | |
| Oranee T. Daniels | M | - | - | |
| Gisela Schwab | M | 67 | 7 years | |
| Randal A. Hassler | M | 66 | 12 years | |
| Richard Nanula | M | 63 | 6 years | |
| Daniel Vapnek | M | 85 | 15 years | |
| Rosemary Mazanet | M | 68 | 5 years | |
| David Hallal | M | 56 | 10 years | |
| David Parkinson | M | 73 | 3 years | |
| Pirow Bekker | M | 63 | 8 years | |
| Denny Lanfear | M | 68 | 13 years | |
| Kathleen M. Wiltsey | F | 68 | 14 years | |
| Lisa A. Evrén | F | - | 5 years | |
| Gregory Stea | M | 66 | 9 years | |
| Nacer E. Dean Abrouk | M | - | 4 years | |
| Lisa Guttman | F | - | 7 years | |
| Juan Jaen | M | 66 | 10 years | |
| Warren Wayne Myers | M | 62 | 10 years | |
| Kimberly Ann Davis | F | 56 | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Martha E. Vincent
- Personal Network
